207 related articles for article (PubMed ID: 35406697)
41. Clinical and genetic diagnosis for 26 paitents with hereditary spherocytosis.
Bai L; Zheng L; Li B; Huang H; Shi X; Yi Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Apr; 48(4):565-574. PubMed ID: 37385619
[TBL] [Abstract][Full Text] [Related]
42. Genotype-degree of hemolysis correlation in hereditary spherocytosis.
Shi Y; Li Y; Yang X; Li X; Peng G; Zhao X; Liu X; Zhao Y; Hu J; Hu X; Zhang B; Zhou K; Yang Y; Xiong Y; Li J; Fan H; Yang W; Ye L; Jing L; Zhang L; Zhang F
BMC Genomics; 2023 Jun; 24(1):304. PubMed ID: 37280519
[TBL] [Abstract][Full Text] [Related]
43. [Genetic Analysis and Prenatal Diagnosis of a Family with Hereditary Spherocytosis Caused by a Novel Compound Heterozygous Mutation of SPTB Gene].
Qin YM; Liao L; Deng XL; Huang J; Wei HY; Lin FQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Apr; 30(2):552-558. PubMed ID: 35395996
[TBL] [Abstract][Full Text] [Related]
44. Improving the laboratory diagnosis of pyruvate kinase deficiency.
Laas C; Lambert C; Senior McKenzie T; Sheldon E; Davidson P; Rees D; Clark B
Br J Haematol; 2021 Jun; 193(5):994-1000. PubMed ID: 33937978
[TBL] [Abstract][Full Text] [Related]
45. [Analysis and prenatal diagnosis of PKLR gene mutations in a family with pyruvate kinase deficiency].
Li D; Zhang J; Jiao B; Liu Y; Wang Y; Wang Z; Li W; Hou L; Sun Y; Guo H; Guo X
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2016 Feb; 33(1):53-6. PubMed ID: 26829734
[TBL] [Abstract][Full Text] [Related]
46. Genetic Diagnosis of Pyruvate Kinase Deficiency in Undiagnosed Iranian Patients with Severe Hemolytic Anemia, using Whole Exome Sequencing.
Mehrabi Sisakht J; Mehri M; Najmabadi H; Azarkeivan A; Neishabury M
Arch Iran Med; 2022 Oct; 25(10):691-697. PubMed ID: 37542401
[TBL] [Abstract][Full Text] [Related]
47. Characterization of hereditary red blood cell membranopathies using combined targeted next-generation sequencing and osmotic gradient ektacytometry.
Vives-Corrons JL; Krishnevskaya E; Rodriguez IH; Ancochea A
Int J Hematol; 2021 Feb; 113(2):163-174. PubMed ID: 33074480
[TBL] [Abstract][Full Text] [Related]
48. Molecular heterogeneity of pyruvate kinase deficiency.
Bianchi P; Fermo E
Haematologica; 2020 Sep; 105(9):2218-2228. PubMed ID: 33054047
[TBL] [Abstract][Full Text] [Related]
49. Residual pyruvate kinase activity in PKLR-deficient erythroid precursors of a patient suffering from severe haemolytic anaemia.
Klei TRL; Kheradmand Kia S; Veldthuis M; Beuger BM; Geissler J; Dehbozorgian J; Karimi M; van Bruggen R; van Zwieten R
Eur J Haematol; 2017 Jun; 98(6):584-589. PubMed ID: 28295642
[TBL] [Abstract][Full Text] [Related]
50. [Clinical characteristics and genetic analysis of hereditary spherocytosis caused by mutations of ANK1 and SPTB genes].
Gong J; He XL; Zou RY; Chen KK; You YL; Zou H; Tian X; Zhu CG
Zhongguo Dang Dai Er Ke Za Zhi; 2019 Apr; 21(4):370-374. PubMed ID: 31014431
[TBL] [Abstract][Full Text] [Related]
51. Targeted next-generation sequencing identifies a novel nonsense mutation in SPTB for hereditary spherocytosis: A case report of a Korean family.
Shin S; Jang W; Kim M; Kim Y; Park SY; Park J; Yang YJ
Medicine (Baltimore); 2018 Jan; 97(3):e9677. PubMed ID: 29505016
[TBL] [Abstract][Full Text] [Related]
52. Hereditary erythrocyte pyruvate-kinase (PK) deficiency and chronic hemolytic anemia: clinical, genetic and molecular studies in six new Spanish patients.
Vives-Corrons JL; Marie J; Pujades MA; Kahn A
Hum Genet; 1980; 53(3):401-8. PubMed ID: 7372343
[TBL] [Abstract][Full Text] [Related]
53. The updated beta-spectrin mutations in patients with hereditary spherocytosis by targeted next-generation sequencing.
Fan J; Yao L; Lu D; Yao Y; Sun Y; Tian Y; Mou L; Chen L; Zhao L; Qiao S; Hu S; Zhu Y
J Hum Genet; 2021 Dec; 66(12):1153-1158. PubMed ID: 34140613
[TBL] [Abstract][Full Text] [Related]
54. Precise diagnosis of a hereditary spherocytosis patient with complicated hematological phenotype.
Liang G; Lin Z; Zhang Y; Zhang Q; Zhu D; Liang X; Xie H; Wei X; Shang X
Mol Genet Genomics; 2024 May; 299(1):57. PubMed ID: 38787432
[TBL] [Abstract][Full Text] [Related]
55. Safety and Efficacy of Mitapivat in Pyruvate Kinase Deficiency.
Grace RF; Rose C; Layton DM; Galactéros F; Barcellini W; Morton DH; van Beers EJ; Yaish H; Ravindranath Y; Kuo KHM; Sheth S; Kwiatkowski JL; Barbier AJ; Bodie S; Silver B; Hua L; Kung C; Hawkins P; Jouvin MH; Bowden C; Glader B
N Engl J Med; 2019 Sep; 381(10):933-944. PubMed ID: 31483964
[TBL] [Abstract][Full Text] [Related]
56. Addressing the diagnostic gaps in pyruvate kinase deficiency: Consensus recommendations on the diagnosis of pyruvate kinase deficiency.
Bianchi P; Fermo E; Glader B; Kanno H; Agarwal A; Barcellini W; Eber S; Hoyer JD; Kuter DJ; Maia TM; Mañu-Pereira MDM; Kalfa TA; Pissard S; Segovia JC; van Beers E; Gallagher PG; Rees DC; van Wijk R;
Am J Hematol; 2019 Jan; 94(1):149-161. PubMed ID: 30358897
[TBL] [Abstract][Full Text] [Related]
57. Identification of new mutations in patients with hereditary spherocytosis by next-generation sequencing.
Qin L; Nie Y; Zhang H; Chen L; Zhang D; Lin Y; Ru K
J Hum Genet; 2020 Apr; 65(4):427-434. PubMed ID: 31980736
[TBL] [Abstract][Full Text] [Related]
58. Deciphering molecular heterogeneity of Indian families with hereditary spherocytosis using targeted next-generation sequencing: First South Asian study.
Aggarwal A; Jamwal M; Sharma P; Sachdeva MUS; Bansal D; Malhotra P; Das R
Br J Haematol; 2020 Mar; 188(5):784-795. PubMed ID: 31602632
[TBL] [Abstract][Full Text] [Related]
59. [Genetic Analysis of a Chinese Pedigree with Hereditary Spherocytosis Caused by Copy Number Variation Deletion of
Chen XL; Li JG; Men Q; Li X
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Feb; 31(1):183-188. PubMed ID: 36765497
[TBL] [Abstract][Full Text] [Related]
60. Compound heterozygosity in
Bagla S; Bhambhani K; Gadgeel M; Buck S; Jin JP; Ravindranath Y
Haematologica; 2019 Sep; 104(9):e428-e431. PubMed ID: 30948487
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
